References
- RiefWNestoriucYWeissSWelzelEBarskyAJHofmannSGMeta-analysis of the placebo response in antidepressant trialsJ Affect Disord20091181819246102
- KhanAKoltsRLRapaportMHKrishnanKRBrodheadAEBrownsWAMagnitude of placebo response and drug-placebo differences across psychiatric disordersPsychol Med20053574374915918351
- KirschIDeaconBJHuedo-MedinaTBScoboriaAMooreTJJohnsonBTInitial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug AdministrationPLoS Med20085260268
- FournierJCDe RubeisRJHollonSDAntidepressant drug effects and depression severity, a patient-level meta-analysisJAMA2010303475320051569
- HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
- LeuchtCHuhnMLeuchtSAmitriptyline versus placebo for major depressive disorderCochrane Database Syst Rev201212CD00913823235671
- MathewSJCharneyDSPublication bias and the efficacy of antidepressantsAm J Psychiatry200916614014519188290
- UndurragaJBaldessariniRJRandomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic reviewNeuropsychopharmacology20123785186422169941
- ArrollBElleyCRFishmanTAntidepressants versus placebo for depression in primary careCochrane Database Syst Rev20093CD00795419588448
- KesslerRCBerglundPDemlerOThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA20032893095310512813115
- ZimmermanMPosternakMAChelminskiISymptom severity and exclusion from antidepressant efficacy trialsJ Clin Psychopharmacol20022261061412454561
- WalshBTSeidmanSNSyskoRGouldMPlacebo response in studies of major depression: variable, substantial and growingJAMA20022871840184711939870
- ParkerGIs depression overdiagnosed? YesBMJ200733532917703041
- PincusHADavisWWMcQueenLE‘Subthreshold’ mental disorders. A review and synthesis of studies on minor depression and other ‘brand names’Br J Psychiatry199917428829610533546
- BarthJSchumacherMHerman-LingenCDepression as a risk factor for mortality in patients with coronary heart disease: a meta-analysisPsychosom Med20046680281315564343
- MastrogiannisDGiamouzisGDardiotisEDepression in patients with cardiovascular diseaseCardiol Res Pract2012201279476222830072
- HaJHWongCKPharmacologic treatment of depression in patients with myocardial infarctionJ Geriatr Cardiol2011812112622783296
- BaumeisterHHutterNBengelJPsychological and pharmacological interventions for depression in patients with coronary artery diseaseCochrane Database Syst Rev20119CD00801221901717
- WeihsKWertJMA primary care focus on the treatment of patients with major depressive disorderAm J Med Sci201134232433021642822
- PrinceMPatelVSaxenaSNo health without mental healthLancet200737085987717804063
- BarbuiCCiprianiAPatelVAyuso-MateosJLvan OmmerenMEfficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysisBr J Psychiatry2011198111621200071
- RutherfordBRMoriSSneedJRPimontelMARooseSPContribution of spontaneous improvement to placebo response in depression: a meta-analytic reviewJ Psychiatr Res20124669770222410207
- BerthelotJMLe GoffBMaugarsYThe Hawthorne effect: stronger than the placebo effect?Joint Bone Spine20117833533621742532
- HaourFMechanism of the placebo effect and of conditioningNeuroimmunomodulation20051219520015990450
- WolfSThe pharmacology of placebosPharmacol Rev19591168970413845665
- GoldsteinAPParticipant expectancies in psychotherapyPsychiatry196225727913899878
- PolloAAmanzioMArslanianACasadioCMaggiGBenedettiFResponse expectancies in placebo analgesia and their clinical relevancePain200193778411406341
- SunshineALaskaEMeisnerMMorganSAnalgesic studies of indomethacin as analyzed by computer techniquesClin Pharmacol Ther19646669970714226185
- AderRThe role of conditioning in pharmacotherapyHarringtonAThe Placebo Effect: An Interdisciplinary ExplorationCambridge, MAHarvard University Press1997
- Di BlasiZHarknessEErnstEGeorgiouAKleijnenJInfluence of context effect on health outcomes. A systemic reviewLancet200135775776211253970
- ThomasKBThe placebo in general practiceLancet1994344106610677934451
- BrodyHThe lie that heals: the ethics of giving placeboAnn Intern Med1982971121187046551
- SinyorMLevittAJCheungAHDoes inclusion of a placebo arm influence response to active antidepressant treatment in RCT? Results from pooled and meta-analysesJ Clin Psychiatry20107127027920122371
- SneedJRRutherfordBRRindskopfDLaneDTSackeimHARooseSPDesign makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depressionAm J Geriatr Psychiatry200816657317998306
- CollocaLMillerFGRole of expectations in healthCurr Opin Psychiatry20112414915521248640
- FrankJDPsychotherapy: the restoration of moraleAm J Psychiatry19741312712744812687
- MarchesiCMagginiCSocio-demographic and clinical features associated with demoralization in medically ill in-patientsSoc Psychiatry Psychiatr Epidemiol20074282482917622475
- KleinDFEndogenomorphic depression. A conceptual and terminological revisionArch Gen Psychiatry1974314474544420562
- de la Fuente-FernándezRThe placebo-reward hypothesis: dopamine and the placebo effectParkinsonism Relat Disord200915 Suppl 3S72S7420083013
- LidstoneSCSchulzerMDinelleKEffects of expectation on placebo-induced dopamine release in Parkinson diseaseArch Gen Psychiatry20106785786520679593
- BloodAJIosifescuDVMakrisNMicrostructural abnormalities in subcortical reward circuitry of subjects with major depressive disorderPLoS One20105e1394521124764
- Der-AvakianAMarkouAThe neurobiology of anhedonia and other reward-related deficitsTrends Neurosci201235687722177980
- ScottDJStohlerCSEgnatukCMWangHKoeppeRAZubietaJKPlacebo and nocebo effects are defined by opposite opioid and dopaminergic responsesArch Gen Psychiatry20086522023118250260
- SeemüllerFMöllerHJObermeierMDo efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trialsJ Clin Psychiatry2010711425143320816028
- PosternakMAZimmermanMTherapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysisBr J Psychiatry200719028729217401033
- IovienoNTedeschiniELevkovitzYAmeralVEPapakostasGIDoes the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trialsInt J Neuropsychopharmacol20111821557881
- WisniewskiSRRushAJNierenbergAACan phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D reportAm J Psychiatry200916659960719339358
- NaudetFMariaASFalissardBAntidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studiesPLoS One20116e2081121687681
- HegerlUMerglRThe clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differencesJ Psychopharmacol20102444544819825901
- KirschIPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences. PrefacePhilos Trans R Soc Lond B Biol Sci20113661781178221576134
- KaptchukTJFriedlanderEKelleyJMPlacebos without deception: a randomized controlled trial in irritable bowel syndromePLoS One20105e1559121203519
- YathamLNKennedySHSchafferACanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disord20091122525519419382
- American Psychiatric AssociationPractice Guideline for the Treatment of Patients With Major Depressive Disorder3rd edArlington, VAAmerican Psychiatric Association2010 Available from: http://www.guidelines.gov/content.aspx?id=24158Accessed June 8, 2013
- National Institute for Clinical ExcellenceThe treatment and management of depression in adults (CG90) Issued Oct 2009. Available from: http://www.nice.org.uk/CG90Accessed June 8, 2013
- AndersonIMFerrierINBaldwinRCEvidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelinesJ Psychopharmacol20082234339618413657
- HansenBHHanashJARasmussenAEffects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD)J Psychosom Res201272111622200516
- TaylorCBYoungbloodMECatellierDENRICHD InvestigatorsEffects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarctionArch Gen Psychiatry20056279279815997021
- LespéranceFFrasure-SmithNKoszyckiDEffects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trialJAMA200729736737917244833